In United Therapeutics Corp. v. Liquidia Techs., Inc., No. 22-2217 , the Federal Circuit affirmed a District of Delaware decision addressing claim construction, validity, and infringement. United.
While direct patent infringement is a strict liability offense, liability for inducing another’s infringement requires an element of intent. Specifically, the party accused of.
The Federal Circuit’s recent decision in United Therapeutics Corp. v. Liquidia Techs., Inc., No. 2022-2217, 2023 WL 4695903 (Fed. Cir. July 24, 2023), provides an interesting discussion.
In Liquidia Techs., Inc. v. United Therapeutics Corp.,[1] the Patent Trial and Appeal Board ("the PTAB") held all challenged claims of U.S. Patent No. 10,716,793 ("the '793 patent") unpatentable under 35 U.S.C. § 103.